As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
About the Editor
Heba Moussa, MD.
Department of Clinical Pathology, National Cancer Institute, Cairo University, Egypt.
Aims and scope
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
About the Society
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Cairo University, accomplishing high quality research in its respected field.
Official journal of
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Egypt.
- ISSN: 2589-0409 (electronic)